查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942851

2026年全球纤维蛋白胶市场报告

Fibrin Sealants Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，纤维蛋白胶市场经历了显着成长，预计到2025年将达到11.7亿美元，到2026年将达到12.7亿美元，复合年增长率（CAGR）为8.4%。过去几年成长要素包括：重组和合成密封剂供应有限、对自体和牛密封剂的依赖、外科手术数量的增加、止血意识的提高以及纤维蛋白胶在普通外科手术中的应用日益广泛。

预计未来几年纤维蛋白胶市场将维持强劲成长，2030年市场规模将达到17.3亿美元，复合年增长率（CAGR）为8.0%。预测期内的成长要素包括重组纤维蛋白生产技术的进步、微创和机器人手术的兴起、心血管和整形外科手术需求的成长、监管核准和品质认证的增加，以及生物可吸收和多功能密封剂的研发。预测期内的主要趋势包括微创手术中纤维蛋白胶的日益普及、重组和合成密封剂的广泛应用、整形外科和心血管外科手术的扩展、对血液保护和止血的日益重视，以及对生物可吸收和贴片式密封剂的偏好不断增强。

预计未来美容手术数量的不断增长将进一步推动纤维蛋白胶市场的扩张。美容手术是一种主要旨在改善或改变外观的医疗程序。美容手术数量的增加与社会对美的日益重视、外科技术的进步以及微创手术的日益普及密切相关。纤维蛋白胶透过加速创伤治疗、减少出血、降低疤痕形成以及改善整体手术效果和恢復情况来辅助美容手术。例如，根据美国整形外科医师协会旗下子公司 CosmetAssure 的数据，截至 2023 年 9 月，抽脂术仍然是 2023 年最常进行的美容手术，共进行了 347,782 例，比 2022 年增长了 7%。同时，腹部手术数量增加了 5%，达到 170,110 例。因此，美容手术数量的成长增强了纤维蛋白胶市场的成长前景。

纤维蛋白胶市场的主要企业正致力于开发创新解决方案，例如纤维蛋白胶，以改善止血效果、减少手术併发症、加速创伤治疗并促进患者復原。纤维蛋白胶是一种源自血液成分的生物黏合剂，能够模拟自然凝血的最后阶段。例如，2024年10月，西班牙生物製药公司Grifols SA的纤维蛋白胶已获得FDA核准，用于治疗儿童患者的手术出血。本产品有助于精准止血，减少术后併发症，并可用于多种外科手术。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球纤维蛋白胶市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 微创手术中纤维蛋白胶的应用日益增多
    • 重组和合成密封剂的使用日益增多
    • 扩大整形外科和心血管外科手术
    • 更加重视血液保护和止血
    • 人们对生物可吸收密封剂和补片密封剂的偏好日益增长

第五章 终端用户产业市场分析

  • 医院
  • 门诊手术中心
  • 整形外科诊所
  • 心血管外科中心
  • 其他专科手术中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球纤维蛋白胶市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球纤维蛋白胶市场规模、对比及成长率分析
  • 全球纤维蛋白胶市场表现：规模与成长，2020-2025年
  • 全球纤维蛋白胶市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 液体、贴片、粉剂
  • 透过技术
  • 自体捐赠、病毒灭活、重组生产及其他技术
  • 透过使用
  • 一般外科、心血管外科、伤口处理、整形外科手术、泌尿系统手术、眼科手术、移植手术等应用
  • 最终用户
  • 医院、门诊手术中心和其他最终用户
  • 按类型细分：液体
  • 牛源性液体密封剂、人类液体密封剂、合成液体密封剂、重组纤维蛋白胶
  • 按类型细分：补丁
  • 牛纤维蛋白贴片、人类纤维蛋白贴片、合成纤维蛋白贴片、生物可吸收纤维蛋白贴片
  • 按类型细分：粉末
  • 牛纤维蛋白粉、人类纤维蛋白粉、合成纤维蛋白粉、重组纤维蛋白粉

第十章 区域与国家分析

  • 全球纤维蛋白胶市场：区域分析、预测（2020-2025年、2025-2030年预测、2035年预测）
  • 全球纤维蛋白胶市场：按国家、性能和预测划分，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 纤维蛋白胶市场：竞争格局与市场份额，2024 年
  • 纤维蛋白胶市场：公司估值矩阵
  • 纤维蛋白胶市场：公司概况
    • Johnson & Johnson
    • Takeda Pharmaceutical Company Limited
    • Asahi Kasei Medical Co. Ltd.
    • Baxter International Inc.
    • CSL Behring

第37章：其他领先和创新企业

  • Grifols SA, Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年纤维蛋白胶市场：提供新机会的国家
  • 2030年纤维蛋白胶市场：新兴细分市场机会
  • 2030年纤维蛋白胶市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MFSEA03_G26Q1

Fibrin sealants, also called fibrin glues or tissue adhesives, are medical products used to support blood clotting and promote tissue healing. Made from fibrinogen and thrombin-proteins involved in natural clot formation-they are commonly used in surgery to control bleeding in delicate areas where stitches or cauterization may not be sufficient.

The primary types in the fibrin sealants market include liquid, patch, and powder formulations. Liquid fibrin sealants contain fibrinogen and thrombin, which combine to form a fibrin clot when applied. These products are used during surgical procedures to control bleeding and enhance tissue bonding and can be administered through methods such as dripping or spraying for accurate placement. The technologies include autologous donation, viral inactivation, recombinant production, and others. The applications span general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgery, ophthalmic surgery, transplant surgery, and others, and the end users include hospitals, ambulatory surgical centers, and other healthcare facilities.

Tariffs have influenced the fibrin sealants market by increasing the cost of imported raw materials and advanced production equipment, including recombinant protein production systems. Segments such as recombinant and synthetic sealants are particularly impacted, with Asia-Pacific regions like China and India facing higher import duties. This has led to increased production costs and potential delays in supply. On the positive side, tariffs encourage local production, investment in domestic manufacturing facilities, and innovation in cost-effective sealant solutions.

The fibrin sealants market research report is one of a series of new reports from The Business Research Company that provides fibrin sealants market statistics, including fibrin sealants industry global market size, regional shares, competitors with a fibrin sealants market share, detailed fibrin sealants market segments, market trends and opportunities, and any further data you may need to thrive in the fibrin sealants industry. This fibrin sealants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fibrin sealants market size has grown strongly in recent years. It will grow from $1.17 billion in 2025 to $1.27 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to limited availability of recombinant and synthetic sealants, reliance on autologous and bovine-derived sealants, increasing surgical procedures, rising awareness about hemostasis, adoption of fibrin sealants in general surgeries.

The fibrin sealants market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to advancements in recombinant fibrin production, growth in minimally invasive and robotic surgeries, increasing demand in cardiovascular and orthopedic procedures, rising regulatory approvals and quality certifications, development of bioabsorbable and multifunctional sealants. Major trends in the forecast period include rising adoption of fibrin sealants in minimally invasive surgeries, increasing use of recombinant and synthetic sealants, expansion of orthopedic and cardiovascular surgeries, growing focus on blood conservation and hemostasis, rising preference for bioabsorbable and patch-based sealants.

The increasing number of cosmetic surgeries is increasingly supporting the expansion of the fibrin sealants market going forward. Cosmetic surgeries are medical procedures primarily performed to enhance or modify physical appearance. The growing volume of cosmetic surgeries is linked to societal emphasis on aesthetics, advancements in surgical techniques, and increased availability of minimally invasive procedures. Fibrin sealants assist cosmetic surgeries by promoting faster wound healing, minimizing bleeding, reducing scarring, and improving overall surgical outcomes and recovery. For example, in September 2023, according to CosmetAssure, a US-based American Society of Plastic Surgeons organization, liposuction remained the most frequently performed cosmetic surgery in 2023 with 347,782 procedures, reflecting a 7% increase from 2022, while tummy tuck procedures rose by 5% to 170,110 cases. Consequently, the rising number of cosmetic surgeries is strengthening growth prospects for the fibrin sealants market.

Leading companies operating in the fibrin sealants market are focusing on developing innovative solutions, such as fibrin sealants, to improve hemostasis, reduce surgical complications, enhance wound healing, and support patient recovery. Fibrin sealants are biological adhesives derived from blood components that replicate the final steps of natural clot formation. For example, in October 2024, Grifols S.A., a Spain-based biopharmaceutical company, received FDA approval for its fibrin sealant for treating surgical bleeding in pediatric patients. The product supports precise hemostasis, reduces postoperative complications, and can be used across a variety of surgical settings.

In July 2024, Corza Medical, a US-based manufacturer of advanced surgical technologies, acquired Takeda's TachoSil manufacturing operations in Linz, Austria, for an undisclosed amount. This acquisition enables Corza Medical to directly manage manufacturing priorities, which is expected to improve service levels and enhance global customer support. Takeda is a Japan-based pharmaceutical company involved in the development and production of fibrin sealants.

Major companies operating in the fibrin sealants market are Johnson & Johnson, Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co. Ltd., Baxter International Inc., CSL Behring, Grifols S.A., Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd., Cohesion Technologies Inc

North America was the largest region in the fibrin sealants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibrin sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fibrin sealants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The fibrin sealants market consists of sales of hemostatic agents, surgical sealants, tissue adhesives, and wound care products. Values in this market are 'factory gate' values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fibrin Sealants Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses fibrin sealants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fibrin sealants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The fibrin sealants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Liquid; Patch; Powder
  • 2) By Technology: Autologous Donation; Viral Inactivation; Recombinant Production; Other Technologies
  • 3) By Application: General Surgery; Cardiovascular Surgery; Wound Management; Orthopedic Surgery; Urological Surgeries; Ophthalmic Surgeries; Transplant Surgery; Other Applications
  • 4) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
  • Subsegments:
  • 1) By Liquid: Bovine-Derived Liquid Sealants; Human-Derived Liquid Sealants; Synthetic Liquid Sealants; Recombinant Fibrin Sealants
  • 2) By Patch: Bovine-Derived Fibrin Patches; Human-Derived Fibrin Patches; Synthetic Fibrin Patches; Bioabsorbable Fibrin Patches
  • 3) By Powder: Bovine-Derived Fibrin Powder; Human-Derived Fibrin Powder; Synthetic Fibrin Powder; Recombinant Fibrin Powder
  • Companies Mentioned: Johnson & Johnson; Takeda Pharmaceutical Company Limited; Asahi Kasei Medical Co. Ltd.; Baxter International Inc.; CSL Behring; Grifols S.A.; Sigma-Aldrich; Nordson Corporation; Integra LifeSciences Corporation; Shanghai RAAS Blood Products Co. Ltd.; Mallinckrodt Pharmaceuticals; Biotest AG; LFB Group; Hualan Biological Engineering Inc.; Corza Medical; Aesculap Inc.; Ethicon Inc.; CryoLife Inc.; VIVEX Biologics Inc.; MediWound Ltd.; Cohesion Technologies Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Fibrin Sealants Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Fibrin Sealants Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Fibrin Sealants Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Fibrin Sealants Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Fibrin Sealants In Minimally Invasive Surgeries
    • 4.2.2 Increasing Use Of Recombinant And Synthetic Sealants
    • 4.2.3 Expansion Of Orthopedic And Cardiovascular Surgeries
    • 4.2.4 Growing Focus On Blood Conservation And Hemostasis
    • 4.2.5 Rising Preference For Bioabsorbable And Patch-Based Sealants

5. Fibrin Sealants Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Orthopedic Clinics
  • 5.4 Cardiovascular Surgery Centers
  • 5.5 Other Specialty Surgery Centers

6. Fibrin Sealants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Fibrin Sealants Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Fibrin Sealants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Fibrin Sealants Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Fibrin Sealants Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Fibrin Sealants Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Fibrin Sealants Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Fibrin Sealants Market Segmentation

  • 9.1. Global Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Liquid, Patch, Powder
  • 9.2. Global Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Autologous Donation, Viral Inactivation, Recombinant Production, Other Technologies
  • 9.3. Global Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • General Surgery, Cardiovascular Surgery, Wound Management, Orthopedic Surgery, Urological Surgeries, Ophthalmic Surgeries, Transplant Surgery, Other Applications
  • 9.4. Global Fibrin Sealants Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Other End-Users
  • 9.5. Global Fibrin Sealants Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bovine-Derived Liquid Sealants, Human-Derived Liquid Sealants, Synthetic Liquid Sealants, Recombinant Fibrin Sealants
  • 9.6. Global Fibrin Sealants Market, Sub-Segmentation Of Patch, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bovine-Derived Fibrin Patches, Human-Derived Fibrin Patches, Synthetic Fibrin Patches, Bioabsorbable Fibrin Patches
  • 9.7. Global Fibrin Sealants Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bovine-Derived Fibrin Powder, Human-Derived Fibrin Powder, Synthetic Fibrin Powder, Recombinant Fibrin Powder

10. Fibrin Sealants Market Regional And Country Analysis

  • 10.1. Global Fibrin Sealants Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Fibrin Sealants Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Fibrin Sealants Market

  • 11.1. Asia-Pacific Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Fibrin Sealants Market

  • 12.1. China Fibrin Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Fibrin Sealants Market

  • 13.1. India Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Fibrin Sealants Market

  • 14.1. Japan Fibrin Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Fibrin Sealants Market

  • 15.1. Australia Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Fibrin Sealants Market

  • 16.1. Indonesia Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Fibrin Sealants Market

  • 17.1. South Korea Fibrin Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Fibrin Sealants Market

  • 18.1. Taiwan Fibrin Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Fibrin Sealants Market

  • 19.1. South East Asia Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Fibrin Sealants Market

  • 20.1. Western Europe Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Fibrin Sealants Market

  • 21.1. UK Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Fibrin Sealants Market

  • 22.1. Germany Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Fibrin Sealants Market

  • 23.1. France Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Fibrin Sealants Market

  • 24.1. Italy Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Fibrin Sealants Market

  • 25.1. Spain Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Fibrin Sealants Market

  • 26.1. Eastern Europe Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Fibrin Sealants Market

  • 27.1. Russia Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Fibrin Sealants Market

  • 28.1. North America Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Fibrin Sealants Market

  • 29.1. USA Fibrin Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Fibrin Sealants Market

  • 30.1. Canada Fibrin Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Fibrin Sealants Market

  • 31.1. South America Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Fibrin Sealants Market

  • 32.1. Brazil Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Fibrin Sealants Market

  • 33.1. Middle East Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Fibrin Sealants Market

  • 34.1. Africa Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Fibrin Sealants Market Regulatory and Investment Landscape

36. Fibrin Sealants Market Competitive Landscape And Company Profiles

  • 36.1. Fibrin Sealants Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Fibrin Sealants Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Fibrin Sealants Market Company Profiles
    • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Asahi Kasei Medical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. CSL Behring Overview, Products and Services, Strategy and Financial Analysis

37. Fibrin Sealants Market Other Major And Innovative Companies

  • Grifols S.A., Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd.

38. Global Fibrin Sealants Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Fibrin Sealants Market

40. Fibrin Sealants Market High Potential Countries, Segments and Strategies

  • 40.1 Fibrin Sealants Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Fibrin Sealants Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Fibrin Sealants Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer